Apelin‐Induced Relaxation is Impaired in Coronary Arteries from Spontaneously Hypertensive Rats

Abstract

Hypertension is a major modifiable risk factor for coronary artery disease. The pathophysiological mechanisms underlying hypertension as a risk factor for coronary artery disease are not fully understood. Apelin is a vasoactive peptide that binds to APJ receptors, which are highly expressed throughout the cardiovascular system, including coronary arteries. APJ receptors signal via G‐protein‐dependent and ‐independent pathways, including activation of G‐protein‐coupled‐receptor kinase 2 (GRK2), which can potentially lead to inhibition of eNOS and nitric oxide (NO) production. We have previously shown that apelin causes endothelium‐dependent, NO‐mediated relaxation of coronary arteries from normotensive animals (JPET 366:265, 2018), but its effects in hypertensive coronary arteries are unknown. Here, we tested the hypothesis that apelin‐induced relaxation is impaired in coronary arteries from spontaneously hypertensive rats (SHR). Western blot analysis demonstrated increased expression of GRK2 in cultured coronary endothelial cells from SHR in comparison with normotensive WKY (control) rats. Isolated coronary arterial rings were mounted in wire myographs for isometric tension recording and contracted with 5‐HT (10‐7 M). Apelin (10‐9‐10‐6 M) caused endothelium‐dependent relaxation of WKY coronary arteries (pD2 = 7.00 ± 0.11; Emax = 54 ± 4% relaxation; n=6), but had no effect in rings from SHR. Conversely, endothelium‐dependent relaxations to an APJ receptor biased agonist, CMF‐019 (10‐9‐10‐5 M), which preferentially activates the G‐protein‐dependent pathway with minimal effect on GRK2, did not differ between SHR and WKY. In the presence of apelin (10‐7 M), endothelium‐dependent relaxation to acetylcholine (ACh) (10‐9‐10‐5 M) was impaired in SHR coronary arteries (pD2 = 6.82 ± 0.10 vs 6.52 ± 0.18, and Emax = 81 ± 8 vs 60 ± 10% relaxation, in the absence and presence of apelin, respectively; n=5; p<0.05); however, apelin had no effect on ACh‐induced relaxation of WKY coronary arteries. By contrast, ACh‐induced relaxation of SHR and WKY coronary arterial rings was unaffected by CMF‐019 (10‐7 M). Moreover, the GRK2 inhibitor, CMPD 101 (3 × 10‐5 M), partially restored the relaxation response to apelin in SHR coronary arteries (pD2 = 6.24 ± 0.30; Emax = 42 ± 13% relaxation; n=3). Relaxations in response to the NO‐donor, DEA NONOate (10‐9‐10‐4 M), were not altered by apelin (10‐7 M) treatment in either WKY or SHR coronary arteries. Taken together, the data indicate that apelin failed to cause relaxation in hypertensive coronary arteries, likely due to impaired production or release of NO from endothelial cells rather than interfering with the action of NO on coronary smooth muscle cells. In SHR coronary arteries, apelin instead actively inhibited relaxation to another endothelium‐dependent vasodilator; i.e. ACh. That the effects of the G‐protein biased agonist, CMF‐019, did not differ between WKY and SHR coronary arteries is consistent with a role for GRK2 activation in the altered response to apelin in hypertensive arteri...